P

Inventor

GOULIAEV ALEX HAAHR

DK35 patents
⚠️ This page may combine multiple inventors who share the name “GOULIAEV ALEX HAAHR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NUEVOLUTION AS

21 patents
US7413854B2Aug 19, 2008

Method for synthesising templated molecules

NUEVOLUTION AS39 citations96
US7704925B2Apr 27, 2010

Ligational encoding using building block oligonucleotides

NUEVOLUTION AS49 citations94
US9284600B2Mar 15, 2016

Method for the synthesis of a bifunctional complex

NUEVOLUTION AS9 citations91
US10287576B2May 14, 2019

Enzymatic encoding methods for efficient synthesis of large libraries

NUEVOLUTION AS19 citations90
US7915201B2Mar 29, 2011

Ligational encoding of small molecules

NUEVOLUTION AS40 citations88
US9885035B2Feb 6, 2018

Method for the synthesis of a bifunctional complex

NUEVOLUTION AS6 citations84
US10077440B2Sep 18, 2018

Method for the synthesis of a bifunctional complex

NUEVOLUTION AS5 citations83
US9487775B2Nov 8, 2016

Method for the synthesis of a bifunctional complex

NUEVOLUTION AS6 citations82
US10689383B2Jun 23, 2020

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

NUEVOLUTION AS6 citations81
US10669538B2Jun 2, 2020

Templated molecules and methods for using such molecules

NUEVOLUTION AS2 citations71
US10683293B2Jun 16, 2020

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

NUEVOLUTION AS3 citations70
US11001835B2May 11, 2021

Method for the synthesis of a bifunctional complex

NUEVOLUTION AS0 citations61
US11254681B2Feb 22, 2022

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

NUEVOLUTION AS1 citations60
US11702652B2Jul 18, 2023

Enzymatic encoding methods for efficient synthesis of large libraries

NUEVOLUTION AS0 citations59
US12441704B2Oct 14, 2025

Compounds active towards nuclear receptors

NUEVOLUTION AS0 citations56
US11685727B2Jun 27, 2023

Compounds active towards nuclear receptors

NUEVOLUTION AS0 citations56
US10731151B2Aug 4, 2020

Method for synthesising templated molecules

NUEVOLUTION AS0 citations52
US11613532B2Mar 28, 2023

Compounds active towards nuclear receptors

NUEVOLUTION AS0 citations50
US9688980B2Jun 27, 2017

Templated molecules and methods for using such molecules

NUEVOLUTION AS0 citations50
US11780843B2Oct 10, 2023

Compounds active towards nuclear receptors

NUEVOLUTION AS0 citations49
US11447479B2Sep 20, 2022

Compounds active towards nuclear receptors

NUEVOLUTION AS0 citations48

NEUROSEARCH AS

5 patents

FRESKGARD PER-OLA

3 patents

GOULIAEV ALEX HAAHR

3 patents

FRANCH THOMAS

1 patent

PEDERSEN HENRIK

1 patent

POSEIDON PHARMACEUTICALS AS

1 patent